ArticleAnalytical and bioanalytical chemistry2026
Rapid detection of apparent amylose in rice using microfluidic paper-based analytical devices based on Ce-UiO66 with high oxidase-like activity.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Apparent amylose content is a key determinant of rice flavor quality, yet traditional detection methods are often costly and time-consuming. To address this, we developed Ce-UiO66 nanozyme-based microfluidic paper-based analytical devices (μPADs) for the rapid quantification of apparent amylose. The sensing mechanism relies on the formation of a blue-purple apparent amylose-iodine complex via in situ catalytic oxidation, which is quantified through smartphone-based grayscale analysis. Mechanistic studies reveal that the catalytic activity of Ce-UiO66 is driven by O
Indexed as
Identifiers
42786301What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.